Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma
Abstract Background As we all know, patients with epithelial ovarian carcinoma have poor prognosis and high recurrence rate. It is critical and challenging to screen out the patients with high risk of recurrence. At present, there are some models predicting the overall survival of epithelial ovarian...
Main Authors: | Jun Hu, Xiaobing Jiao, Lirong Zhu, Hongyan Guo, Yumei Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07402-2 |
Similar Items
-
Validated Prognostic Nomograms for Patients With Parotid Carcinoma Predicting 2- and 5-Year Tumor Recurrence-Free Interval Probability
by: Sam Peeperkorn, et al.
Published: (2020-08-01) -
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
by: Wonkyo Shin, et al.
Published: (2018-05-01) -
Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma
by: Yang YC, et al.
Published: (2021-06-01) -
Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study
by: Hsin-Ying Huang, et al.
Published: (2021-06-01) -
A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
by: Junjie Kong, et al.
Published: (2019-10-01)